机构:[1]Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.四川大学华西医院[2]Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.四川大学华西医院[3]Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-Related Molecular Network, Sichuan University, Chengdu, Sichuan 610041, China.[4]Department of Clinical Medicine, Southwest Medical University, Luzhou, Sichuan 646000, China.[5]Department of Pulmonary and Critical Care Medicine, Laboratory of Precision Therapeutics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.四川大学华西医院[6]Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.四川大学华西医院[7]Department of Thoracic Surgery, Sichuan Cancer Hospital & Institute Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, Sichuan 610041, China.外科中心胸外科中心四川省肿瘤医院
This study was supporte by a grant (Gyyx24008) from the 1-3-5 Project of the Center for High Altitude Medicine, West China Hospital, Sichuan University.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类|2 区医学
小类|2 区医学:内科
最新[2025]版:
大类|2 区医学
小类|2 区医学:内科
第一作者:
第一作者机构:[1]Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.[2]Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
共同第一作者:
通讯作者:
通讯机构:[1]Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.[2]Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
推荐引用方式(GB/T 7714):
Li Pengfei,Wang Xin,Gu Miqi,et al.Survival outcomes of radical surgery after induction chemoimmunotherapy in clinical stage IIIA-IIIB (N2) non-small cell lung cancer[J].Chinese Medical Journal.2025,doi:10.1097/CM9.0000000000003664.
APA:
Li Pengfei,Wang Xin,Gu Miqi,Huang Kaili,Tian Long...&Zhou Qinghua.(2025).Survival outcomes of radical surgery after induction chemoimmunotherapy in clinical stage IIIA-IIIB (N2) non-small cell lung cancer.Chinese Medical Journal,,
MLA:
Li Pengfei,et al."Survival outcomes of radical surgery after induction chemoimmunotherapy in clinical stage IIIA-IIIB (N2) non-small cell lung cancer".Chinese Medical Journal .(2025)